Cargando…
Targeted vaccination and the speed of SARS-CoV-2 adaptation
The limited supply of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) raises the question of targeted vaccination. Many countries have opted to vaccinate older and more sensitive hosts first to minimize the disease burden. However, what are the evolutionary consequences...
Autores principales: | Gandon, Sylvain, Lion, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784131/ https://www.ncbi.nlm.nih.gov/pubmed/35031567 http://dx.doi.org/10.1073/pnas.2110666119 |
Ejemplares similares
-
On the evolutionary epidemiology of SARS-CoV-2
por: Day, Troy, et al.
Publicado: (2020) -
Ongoing global and regional adaptive evolution of SARS-CoV-2
por: Rochman, Nash D., et al.
Publicado: (2021) -
The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022) -
A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants
por: Pishesha, Novalia, et al.
Publicado: (2021) -
Targeting spike glycans to inhibit SARS-CoV2 viral entry
por: Guseman, Alex J., et al.
Publicado: (2023)